Explore emerging IgA nephropathy therapies—complement and BAFF/APRIL inhibitors, targeted budesonide—and why long‑term safety data still lags. In this episode, Overcoming Access Barriers and Step-Edit ...
A multi-center retrospective cohort study examined how cangrelor has been used in real-world clinical practice around the time of surgery following percutaneous coronary intervention (PCI) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results